Market Overview

Morgan Stanley Upgrades Dean Foods, Cites 'More Balanced' 2018


Shares of Dean Foods Co (NYSE: DF) have lost more than 40 percent over the past year, but one analyst sees a "more balanced" setup for 2018.

The Analyst

Morgan Stanley's Matthew Grainger upgraded Dean Foods' stock from Underweight to Equal-Weight with an unchanged $11 price target.

The Thesis

Many of the fundamental pressures plaguing Dean Foods over the past year remains unchanged but after a more than 40 percent decline in the stock in 2017, the setup for 2018 is more balanced, Grainger said in a note. Specifically, the company's EBIT profile of $0.073 per gallon is unchanged but the company can now benefit from an approximate 10 percent decline in Class I milk costs and an improvement in private label margins. Other tailwinds that were not present in 2017 include more aggressive cost savings, portfolio optimization measures, and a benefit from tax reform.

Dean Foods' stock is now trading at a 5.8 times C2018 EV/EBITDA multiple, which represents a discount to its five-year average of 6.3 times, Grainger said. The analyst's $11 price target implies a 5.5 times multiple, which implies minimal downside potential in 2018.

Price Action

Shares of Dean Foods traded higher by more than 3 percent Wednesday morning, but neared the close up less than 1 percent at $11.35.

Related Links:

Cocoa Costs Can't Sweeten Hershey: Morgan Stanley Downgrades To Sell

Analyst: Kroger Shows 'Continued Experimentation And Learning' With In-Store Food Service

Latest Ratings for DF

Feb 2019MaintainsMarket PerformMarket Perform
Nov 2018MaintainsUnderperformUnderperform
Nov 2018DowngradesBuyHold

View More Analyst Ratings for DF
View the Latest Analyst Ratings

Posted-In: food food stocks Matthew Grainger Milk Milk PricesAnalyst Color Upgrades Analyst Ratings


Related Articles (DF)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Credit Suisse: Encompass Health Is The Market Leader In Rehab, Home Health

Wall Street Reacts To Celgene's Reported Interest In Juno